Harmony Biosciences Holdings (HRMY)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 579,252 | 451,070 | 400,285 | 284,439 | 262,891 |
| Total current liabilities | US$ in thousands | 175,082 | 163,781 | 78,884 | 53,775 | 134,539 |
| Current ratio | 3.31 | 2.75 | 5.07 | 5.29 | 1.95 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $579,252K ÷ $175,082K
= 3.31
The current ratio of Harmony Biosciences Holdings has shown fluctuation over the years based on the provided data. As of December 31, 2020, the current ratio stood at 1.95, indicating that the company had almost enough current assets to cover its current liabilities. However, there has been a significant improvement in liquidity position in the following years, with the ratio increasing to 5.29 as of December 31, 2021, and 5.07 as of December 31, 2022. This suggests a strong ability to meet short-term obligations using current assets.
In the subsequent years, the current ratio declined but remained above 2, indicating continued liquidity strength. As of December 31, 2023, the ratio was 2.75, and as of December 31, 2024, it stood at 3.31. Although there was a slight reduction in liquidity compared to the previous years, the company still had more than enough current assets to cover its short-term liabilities.
Overall, the trend in Harmony Biosciences Holdings' current ratio reflects a generally strong liquidity position, with fluctuations indicating variations in the company's ability to meet short-term obligations over the years.
Peer comparison
Dec 31, 2024